Acute Lymphoid Leukemia

About
Mappings

OncoTree: Acute Lymphoid Leukemia (coding:oncotree:ALL)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organizations Biomarkers Cancer types Therapies
EMA (1) FDA (2) CD19 + Acute Lymphoid Leukemia Blinatumomab
EMA (5) FDA (1) CD19 +, not BCR::ABL1 Acute Lymphoid Leukemia Blinatumomab
FDA (2) BCR::ABL1 Acute Lymphoid Leukemia Dasatinib
FDA (2) CD33 + Acute Lymphoid Leukemia Gemtuzumab ozogamicin
FDA (2) BCR::ABL1 Acute Lymphoid Leukemia Imatinib
EMA (2) FDA (1) CD22 + Acute Lymphoid Leukemia Inotuzumab ozogamicin
EMA (1) FDA (1) BCR::ABL1 Acute Lymphoid Leukemia Cytarabine, Dexamethasone, Methotrexate, Ponatinib, Prednisone, Vincristine
FDA (1) ABL1 p.T315I, BCR::ABL1 Acute Lymphoid Leukemia Ponatinib
FDA (1) t(KMT2A;v) Acute Lymphoid Leukemia Revumenib
EMA (2) CD22 +, not BCR::ABL1 Acute Lymphoid Leukemia Inotuzumab ozogamicin
EMA (2) not BCR::ABL1 Acute Lymphoid Leukemia Imatinib
EMA (1) not BCR::ABL1 Acute Lymphoid Leukemia Ponatinib
EMA (1) ABL1 p.T315I, not BCR::ABL1 Acute Lymphoid Leukemia Ponatinib
EMA (2) not BCR::ABL1 Acute Lymphoid Leukemia Dasatinib
FDA (1) NPM1 p.W288Cfs*12 Acute Lymphoid Leukemia Revumenib